Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy

• Status: Unknown status
• Trial end date: 2021-04-10
• Target enrollment: 0
• Participant gender: All

Summary

To study the clinical efficacy and safety of autologous umbilical cord blood transfusion in the treatment of cerebral palsy.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guangdong Women and Children Hospital

Criteria

Inclusion Criteria:

• A patient who was diagnosed with a mild case, and severity case of cerebral palsy or developmental disability through developmental assessment from more than two specialists including a specialist in pediatrics and rehabilitation medicine..

• In case there is a sign of the general decrease in white matter, or periventricular leukomalacia near cerebral ventricles in MRI DTI test.

• A subject who did a written consent to participation in this clinical trial through the very person and a legal representative.

Exclusion Criteria:

• In case a patient underwent a surgical procedure, or was administered autologous cord blood within one year before participating in a clinical trial.

• Accompanied by a serious disease, such as chromosome abnormality, etc.

• In case where a patient's medical condition is judged to be maladapted by a researcher.

• In case a patient or his or her legal representative doesn't agree to participation in a clinical trial.

• A patient having a predisposition to allergies.

• A patient having serious disorders in the liver, kidney, and cardiopulmonary function.